LEAVO: A multicentre double-masked randomised non-inferiority clinical trial

New funded trial by UMS member: Professor Toby Prevost

2014-2018       LEAVO: A multicentre double-masked randomised non-inferiority clinical trial comparing the clinical and cost effectiveness of intravitreal ranibizumab (Lucentis), aflibercept (Eylea)and bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion.

PI: P.Hykin (Moorfields). NIHR HTA 11_92_03 £2.3m (53 months).

http://www.nets.nihr.ac.uk/projects/hta/119203

Advertisements